OI Stock Recent News
OI LATEST HEADLINES
The average of price targets set by Wall Street analysts indicates a potential upside of 52.2% in O-I Glass (OI). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
O-I Glass, Inc. has reported weak financials due to weak recent industry trends. The company anticipates a gradual recovery with stable y/y volumes in Q2, but I believe that investors should be cautious of the upcoming quarterly report. The extensive investments in the MAGMA program should aid earnings in coming years, potentially making the stock undervalued.
PERRYSBURG, Ohio, July 03, 2024 (GLOBE NEWSWIRE) -- O-I Glass, Inc. (NYSE: OI) has scheduled its second quarter 2024 conference call and webcast for Wednesday, July 31, 2024, at 8 a.m. EDT. The Company's news release for the second quarter 2024 earnings will be issued after the market closes on Tuesday, July 30.
Perrysburg, Ohio, July 02, 2024 (GLOBE NEWSWIRE) -- O-I Glass, Inc. (“O-I Glass” or “O-I”) plans a major transformation of its Alloa, UK manufacturing plant into an even more technologically advanced facility with an expected significant reduction in CO2 emissions.
Company 2024 Sustainability Report Update Showcases Significant Progress Toward Ambitious Sustainability Goals Company 2024 Sustainability Report Update Showcases Significant Progress Toward Ambitious Sustainability Goals
Energy storage system at O-I's Alloa, UK, plant helps balance the grid, reduces peak load, optimizes the use of renewable electricity, and increases O-I's resilience against brownouts Energy storage system at O-I's Alloa, UK, plant helps balance the grid, reduces peak load, optimizes the use of renewable electricity, and increases O-I's resilience against brownouts
O-I Glass (OI) to invest in the electrification and decarbonization of its plant in Veauche.
14-month data show treatment with setrusumab resulted in a large, sustained 67% reduction in annualized fracture rate and persistent median annualized fracture rate of 0.00 (p=0.0014)
Lower sales volumes impact O-I Glass' (OI) performance, thereby reflecting the current inventory destocking actions and weak consumer demand in a few markets.